✦ LIBER ✦

Isoflurane therapy for severe refractory status asthmaticus in children

✍ Scribed by Venkat Shankar; Kevin B. Churchwell; Jayant K. Deshpande

Publisher: Springer
Year: 2006
Tongue: English
Weight: 276 KB
Volume: 32
Category: Article
ISSN: 1432-1238
DOI: 10.1007/s00134-006-0163-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose midazolam therapy for refracto

High-dose midazolam therapy for refractory status epilepticus in children

✍ Gavin Morrison; Elizabeth Gibbons; William Patrick Whitehouse 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 298 KB

Multiple combined therapy for severe Hen

Multiple combined therapy for severe Henoch-Schönlein nephritis in children

✍ Kazumoto Iijima; Seiko Ito-Kariya; Hajime Nakamura; Norishige Yoshikawa 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 167 KB

α-interferon therapy for severe chronic

α-interferon therapy for severe chronic idiopathic thrombocytopenic purpura in children

✍ Dr. Richard J. Cohn; Rosemarie Schwyzer; Janet E. Poole; Peter B. Hesseling; Joa 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB 👁 1 views

Midazolam for refractory status epilepti

Midazolam for refractory status epilepticus in children: higher dosing and more rapid and effective control

✍ Robert C. Tasker 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 50 KB

Use of intravenous isoproterenol for sta

Use of intravenous isoproterenol for status asthmaticus in children: Herman JJ, Noah ZL, Moody RR Crit Care Med 11:716–720 Sep 1983

✍ Marc J Gorayeb 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Outcomes and adverse events in children

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis

✍ Sheree Watson; Licia Pensabene; Paul Mitchell; Athos Bousvaros 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Background: Children with severe corticosteroid-resistant ulcerative colitis either need to undergo surgery or be treated with more intensive immunosuppression. Our aim was to characterize the short-and long-term outcomes and adverse events associated with the use of tacrolimus in a steroid-refracto